Premier Alternatives

RejuvenAir

Lexington, MA · Founded 1993 · Privately Held (backing)

Developer of an interventional device designed to offer the therapy of chronic obstructive pulmonary disease with chronic bronchitis using metered cryospray. RejuvenAir is based in Lexington, MA and was founded in 1993. Its last known valuation is $156 million. It has raised $191 million.

Last price · $/share
—
Implied valuation
$156.0M
Total raised
$191.4M
Last round
—
What is RejuvenAir worth?
$156.0Mlast known valuation
Free account
More of RejuvenAir with a free account
  • ·The complete investor list: 12 names
  • ·Watch RejuvenAir: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

RejuvenAir funding history

No rounds on record

No funding rounds for RejuvenAir are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

RejuvenAir valuation

RejuvenAir's last known valuation is $156 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How RejuvenAir's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For RejuvenAir, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about RejuvenAir

What is RejuvenAir worth?
RejuvenAir's last known valuation is $156.0M.
How much has RejuvenAir raised?
RejuvenAir has raised $191.4M in total funding across its recorded rounds.